Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: A randomized, open-label, placebocontrolled multicenter trial

Charles J. Fisher, Michael A. Catalano, Gus J. Slotman et al.|Critical Care Medicine|1994

Cited by 490